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SUMMARY
Chronic neuropathic pain is amajor morbidity of neu-
ral injury, yet itsmechanisms are incompletely under-
stood. Hypersensitivity to previously non-noxious
stimuli (allodynia) is a common symptom. Here, we
demonstrate that the onset of cold hypersensitivity
precedes tactile allodynia in a model of partial nerve
injury, and this temporal divergence was associated
with major differences in global gene expression in
innervating dorsal root ganglia. Transcripts whose
expression change correlates with the onset of cold
allodynia were nociceptor related, whereas those
correlating with tactile hypersensitivity were immune
cell centric. Ablation of TrpV1 lineage nociceptors re-
sulted in mice that did not acquire cold allodynia but
developed normal tactile hypersensitivity, whereas
depletion of macrophages or T cells reduced neuro-
pathic tactile allodynia but not cold hypersensitivity.
We conclude that neuropathic pain incorporates
reactive processes of sensory neurons and immune
cells, each leading to distinct forms of hypersensitiv-
ity, potentially allowing drug development targeted
to each pain type.
INTRODUCTION
Peripheral neuropathic pain in animal models is associated with
hypersensitivity to noxious and non-noxious stimuli in areas of
tissue that neighbor those normally innervated by the damaged
nerves. Changes both in the peripheral nervous system (PNS)
and central nervous system (CNS) contribute to the development
of this pain hypersensitivity (Costigan et al., 2009b). Global gene
expression studies in the adult rodent dorsal root ganglia (DRG)
in response to sciatic nerve injury have helped define the
peripheral mechanisms likely to contribute to the changes in
neuropathic pain-like hypersensitivity (Costigan et al., 2009b;
LaCroix-Fralish et al., 2011), as well as novel targets for therapy
(Dib-Hajj and Waxman, 2014; Tegeder et al., 2006).
Following sciatic nerve injury, the ipsilateral L3-5 lumbar DRGs
contain the cell bodies of injured and non-injured primary
sensory neurons, satellite cells, fibroblasts, and blood vessels,
as well as resident immune cells and those recruited from the
blood (Hu et al., 2007). Peripheral nerve injury induces transcrip-
tional changes in each of these diverse cell types (Costigan et al.,
2002, 2010; Watkins andMaier, 2002). Peripheral nerve injury in-
duces pain-like hypersensitivity in rodents that develops over the
first week or so following the axonal damage (Colleoni and
Sacerdote, 2010; Jaggi et al., 2011). Here, we have determined
the onset of two chronic pain-like sensory modalities (tactile
and cold allodynia) in C57BL/6 mice at high temporal resolution
(daily) over the first 10 days in the spared nerve injury (SNI) model
(Decosterd and Woolf, 2000), and we found clear differences
in their temporal evolution, with cold sensitivity developing
quicker than tactile allodynia. The temporal separation of these
two clinically important neuropathic pain modalities (Jensen
and Finnerup, 2014) led us to design a global gene expression
study in lumbar DRGs ipsilateral to the nerve injury to directly
correlate the relative timing of transcript expression and sensory
modality changes.
We demonstrate differences in the kinetics of early neuronal
and late immune gene regulation events, changes which closely
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mirror the onset of cold and tactile allodynia respectively.
These data indicate that different cellular and molecular mecha-
nisms may be responsible for development of tactile and cold al-
lodynia in the damaged PNS, which we confirmed by selectively
targeting the immune and nervous systems. Understanding the
differences in pain hypersensitivity features should allow us
to develop new therapies tailored to their distinct underlying
mechanisms.
RESULTS
Onset of Cold and Tactile Allodynia
Tactile and cold allodynia both develop subsequent to peripheral
nerve injury and are major clinical concerns of neuropathic pain
patients (Jensen and Finnerup, 2014). A high-density time-
course analysis of neuropathic pain-related behavioral onset
showed that cold and tactile hypersensitivity developed to
maximal levels in the first week after nerve injury and persisted
for at least 15 days. Cold allodynia developed relatively quickly,
reaching a statistically significant increase at 3 days and
achieving peak levels 4–5 days post-SNI (Figure 1A); however,
tactile allodynia became established over a slower time frame,
with a statistically significant decrease of the mechanical
threshold at 5 days and reaching maximal levels 7–8 days
post-SNI (Figures 1B and 1C). These data agreewith previous re-
ports in which cold allodynia develops faster than mechanical
hypersensitivity (Decosterd and Woolf, 2000; Pertin et al.,
2007; Wijnvoord et al., 2010). Sham-operated controls did not
show alterations in either cold or tactile hypersensitivity (Figures
1A and 1B, respectively).
Transcripts Regulated in the DRG Post-SNI
The differences in the onset time of cold and tactile allodynia led
us to consider if these pain modalities may have different mech-
anisms. To investigate this, we performed an expression array
profiling experiment over a similar high-resolution time course
to the behavioral studies. We evaluated global gene expression
in the ipsilateral DRG daily for the first 10 days post-SNI and also
at 8 and 16 hr post-SNI.
We initially assessed changes in gene expression in the DRG
over 10 days post-SNI in all 1,704 probes differentially regulated
over time between naive and injured conditions (moderated F-
statistic, p < 0.01; Table S1) by a weighted gene co-expression
network analysis (WGCNA) (Parikshak et al., 2015). By employ-
ing amodulemerger step that used Euclidean distance to cluster
the average module regulation patterns across time (not shown),
wewere able to reveal eight distinct expression clusters (clusters
I–VIII) comprising 1,699 of the regulated probes (Figure 2) and 5
additional probes that did not fit in any of the eight clusters
(Table S1). Ingenuity Pathway Analysis (IPA) of content of each
cluster annotated their general functional identity, which delin-
eate the most overrepresented descriptors of gene function
assigned to each transcript in each cluster (see ‘‘Function/Cell
type’’ and ‘‘Example Genes’’ in Figure 2).
A similarity plot of average gene expression across time for
each cluster demonstrates that each has distinct expression pat-
terns, although similarities are observed between clusters III and
VI (two of the neuronal modules), and also between the clusters
VII and VIII (mixed function and late immune) (Figure 3A). By plot-
ting the relative expression of each gene cluster across time, we
could identify four cluster groups with distinct kinetic patterns
(Figures 3B–3E). Genes in cluster I (largely chemotaxis related)
showed an immediate but short-lived expression change that
A
B
C
Figure 1. Differences in the Onset of Cold and Tactile Allodynia
(A and B) Cold allodynia (A) develops relatively quickly post-injury, whereas
tactile allodynia (B) develops at a slower pace.
(C) The onset time of cold hypersensitivity is illustrated by the blue line (cold)
relative to the later onset of tactile hypersensitivity illustrated by the orange line
(tactile).
Statistically significant differences between the values frommice after SNI and
their basal measures in (A) and (B); *p < 0.01 (one-way repeated-measures
ANOVA followed by Bonferroni post hoc test). There were no statistically
significant differences between basal measures and values after sham
surgery (gray lines, one-way repeated-measures ANOVA). Error bars indicate
SEM (n = 13 or 14 per group; see Supplemental Experimental Procedures).
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peaked several hours post-SNI (Figure 3B). The next kinetic
group contained the predominantly neuronal regulatory clusters
II, III, andVI,whichdisplay amonophasic expressionpattern (Fig-
ure 3C). Clusters II and III demonstrate a late decrease in relative
expression, although average expression did not fall back to
baseline by 10 days post-SNI. In contrast, the expression level
of cluster VI remained at or around maximal levels until 10 days
after SNI.Next, genes in clusters IVandV initially showedadown-
regulation in reaction to the injury and then displayed a relatively
strong increase that peaked at 3 days after nerve injury before
settling to approximately naive levels at later time points (Fig-
ure 3D). The final kinetically distinct group contained two clusters
that demonstrated sustained increases of expression, reaching
maximal levels over 10 days, with the rise of cluster VII (mixed
neuronal/support cell and immune) preceding that of cluster VIII
(late immune) (Figure 3E). Each cluster contains not only genes
regulated in the direction depicted in Figures 3B–3E but also
Figure 2. WGCNA Analysis of All Regulated
Transcripts in DRG
Significantly regulated probes (moderated F-
statistic, n = 1,704) were subject to WGCNA
analysis to produce unbiased clusters of co-
regulated transcripts representing the entire
regulatory network of transcripts in the DRG
following peripheral nerve injury (SNI) for 10 days
sampled at least once a day over this period. The
first column defines the clusters present, and the
second shows heatmaps of each gene in each
cluster. Blue represents low-level expression and
red high-level expression. The third column gives
a brief description of cluster function as defined
by IPA software. Below this is the number of
probes in each cluster and the p value IPA
ascribed the function given. The final column
gives example transcripts from each functional
subdivision. See also Table S1.
genes regulated in a pattern mirroring
that shown (reciprocal regulation events).
Figure 2 shows all gene regulation pat-
terns both positive and negative.
We performed a transcription factor
binding site (TFBS) enrichment analysis
for each of the eight clusters to uncover
the potential regulatory network contrib-
uting to the observed gene regulation
patterns after nerve injury. To avoid
confounders and identify only the most
statistically robust sites, we used 3
different control datasets as background
(1,000 bp sequences upstream of all
mouse genes, mouse CpG islands, and
the mouse chromosome 19 sequence).
We identified 210 TFs (Figure S1A) whose
DNA binding motifs were over repre-
sented in the promoters of each gene
cluster set (Table S2). Interestingly, hier-
archical clustering of the TFBS enrich-
ment score for each cluster revealed a separation of neuronal
and immune-associated gene modules, suggesting distinct
regulatory control by transcription of these gene sets after nerve
injury (Figure S1A).
To identify potential protein signaling pathways operational
after nerve injury, we determined the protein-protein interaction
(PPI) network represented by all the differentially regulated
genes (see Experimental Procedures). We screened for experi-
mentally validated PPI among all possible combinations of
gene pairs present in the DRG regulated gene set, obtaining a
PPI network consisting of 310 nodes and 442 edges. This re-
vealed certain key signaling molecules such as ATF3, JUN,
BDNF, mitogen-activated protein kinase 1/3 (MAPK1/3), trans-
forming growth factor b1 (TGF-b1), STAT3, TCF3, CCR5, and
interleukin-1b (IL-1b) (Figure S2) and certain transcription factors
(TFs) as major hubs, potentially regulating many of the genes
present in the global injury response; including SP1, ESR1,
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SMAD3, TP53, and STAT5A (Figure S2). Next, by screening for
signaling pathways in the PPI network, we observed enrichment
of several important signaling pathways that may contribute to
nerve injury response, including the neurotrophin, MAPK, TGF-
b, chemokine, and ErbB signaling pathways (Table S3). To iden-
tify signaling cascades activated over time after nerve injury, we
also examined for the presence of signaling pathway genes in
each cluster. These analyses show that there is a group of
strongly represented neuronal signaling pathways, including
NGF, EGFR, p38MAPK, and TGF-b in clusters III, IV, and VII (Fig-
ure S3), suggesting co-activation of multiple signaling pathways
in response to nerve injury (Abe and Cavalli, 2008).
Analysis of the full gene expression dataset suggested a
generalized kinetic separation of groups of neuronal and im-
mune-rich transcripts across time, such that overall neuronal
gene changes preceded alterations in immune transcript expres-
sion in the DRG over the first 10 days after nerve damage (Fig-
ures 3C and 3E, respectively). This led us to consider whether
such expression differences could reveal information on the
functional origins of the diverse behavioral manifestations of
neuropathic pain.
Genes Correlated with Cold and Tactile Allodynia in the
DRG
To define those transcripts with expression changesmost corre-
lated with cold and tactile allodynia, we chose transcripts with a
Pearson correlation coefficient greater than 0.85 (directly corre-
lated) or less than 0.85 (inversely correlated) with each behav-
ioral hypersensitivity onset curve (Figures 4A and 4B). The cold
allodynia time course closely correlated with the temporal
pattern of 145 probes, corresponding to 137 distinct transcripts,
of which 107 (78%) were upregulated and 30 (22%) were down-
regulated (Figure 4A). The list of the transcripts correlated with
cold allodynia and their Pearson correlation values can be found
in Table S4. For tactile allodynia, we identified 40 probes, corre-
sponding to 36 distinct transcripts whose expression closely
correlated to the onset of mechanical sensitivity. Of these, 33
transcripts (92%) were upregulated and 3 (8%) were downregu-
lated (Figure 4B). The list of the transcripts correlated with tactile
allodynia and their Pearson correlation values can be found in
Table S5.
We performed a biological validation of the gene lists that
made up the cold- and tactile- correlated groups by comparing
these lists with results from DRG transcriptome profiling ob-
tained using RNA sequencing (RNA-seq) (naive and 1, 3, and
7 days after SNI) from biologically distinct tissue to that used in
the array studies. We found 116 common genes in the acetone
(neuronal) list and 36 common genes in the von Frey (immune)
list in both platforms. The heatmaps of common genes from
the arrays and RNA-seq for each sensory modality are shown
in Figures S2A–S2D, and these data demonstrate that the overall
A
B
C
D
E
Figure 3. Transcript Regulation in the DRGafter SNI FollowsDistinct
Patterns
(A) Similarity plot of the module eigengenes of each cluster showing very little
overlap in pattern regulation.
(B–E) Representations of the regulation of each cluster given as singles line
plots with intensity of regulation on the y axis and time on the x axis. Cluster I
(B), clusters II, III, and VI (C), clusters IV and V (D), and clusters VII and VIII (E).
Each cluster contains not only genes regulated in the fashion drawn but also
reciprocal regulation events.
See also Figures S1, S2, and S3 and Tables S1, S2, and S3.
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expression patterns of the constituent genes were virtually iden-
tical regardless of the platform used to define gene regulation.
This RNA-seq dataset also allows validation of the other regu-
lated transcripts described in Figure 2.
When the group of genes correlated with cold allodynia was
processed by IPA, ‘‘Neurological disease’’ was the top biological
function defined for 33 genes (24%). ‘‘Seizures,’’ ‘‘Migraines,’’
and ‘‘Neuropathic pain’’ were also among functional subgroups
identified as present (Figure 4C). (See Table S6 for the content of
genes in each annotated function.) In contrast, for the group of
genes significantly correlated with tactile allodynia, with IPA,
‘‘Immune disease’’ was identified as the top biological function,
with 19 transcripts (53%). ‘‘Systemic autoimmune syndrome,’’
‘‘Antigen presentation activation,’’ ‘‘Insulin-dependent diabetes
mellitus,’’ and ‘‘Rheumatoid arthritis’’ were other functional
subgroups identified as present (Figure 4D). (See Table S7 for
the content of genes in each annotated function.)
To further assay genes associated with the development of
cold and tactile allodynia, we investigated amore inclusive group
of transcripts including those genes directly and inversely corre-
lated with a Pearson coefficient of correlation >0.75 (see Exper-
imental Procedures). These gene sets were then subjected to
C
D
E
GA
B F
Figure 4. Transcript Expression in the DRG Correlating with the Temporal Profile of Cold Allodynia Was Nociceptor Related, whereas That
with Tactile Hypersensitivity Was Immune Cell Centric
Gene expression was correlated with the time courses of cold and tactile allodynia development using the Pearson coefficient of similarity.
(A) Heatmap of the relative expression of the probes that most tightly correlate with cold allodynia onset.
(B) Relative expression of the probes that most tightly correlate with tactile allodynia.
(C and D) Representative functional characteristics using IPA of these cold- (C) and tactile-related (D) transcripts.
(E and F) Strongest GO terms for transcripts correlated with cold (E) and tactile (F) allodynia.
(G) Cross-comparison of transcripts present in each cluster with transcript lists derived from isolated DRGnociceptors and isolatedmacrophages/T cells. Orange
represents genes contained only in the immune gene list, blue represents genes contained only in the nociceptor list, gray represents genes present in both lists,
and white represents genes not contained in either list.
See also Tables S4, S5, S6, S7, S8, and S9 and Figure S4.
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Gene Ontology (GO) analysis to find the most related functional
terms (Figures 4E and 4F). Transcripts in this set whose expres-
sion over time correlated with the onset of cold allodynia
(375 probes) were almost entirely related to neuronal function
(Figure 4E). (See Table S8 for the content of genes in each anno-
tated function.) The genes most related to the development of
tactile allodynia in the GO analysis were almost entirely related
to immune function (130 probes). (See Table S9 for the content
of genes in each annotated function.) Both GO analyses accord
with the IPA-based data (shown in Figures 4E and 4F).
An enrichment of a particular IPA functional annotation or GO
category signifies that multiple genes participating in the same
process correlate with the phenotype in question. Using two
thresholds of correlation allowed us to span the expression
data more exhaustively than using one. The fact that each of
these lists result in very complementary functional descriptions
using two different pathway search tools with different correlated
transcript inclusion criteria represents an internal control for the
validity of the associations.
We also compared the cold- and tactile-allodynia-correlated
transcripts to previously published analyses of genes specifically
expressed either in nociceptor DRG neurons (Chiu et al., 2014) or
in activated macrophages and T cells (Brown et al., 2015; Rosas
et al., 2014) (see Experimental Procedures). This analysis revealed
that 37% of the genes identified as correlated with cold allodynia
are expressed specifically in nociceptors, with 16% specific to
leukocytes. Using the same approach to assay genes whose
expression correlates with tactile allodynia, 51% are specifically
expressed in leukocytes, with only 6% specific to nociceptors.
Therefore, transcripts correlated with the onset of tactile allodynia
have a stronger immune component than neuronal, with the
reverse holding true for cold allodynia (Figure 4G).
TrpV1 Lineage Neurons and Neuropathic Allodynia
To determine if changes in a specific set of DRG sensory
neurons are responsible for development of cold allodynia
post-SNI, we examined TrpV1CreDTAflox-stop mice that lack
TrpV1-lineage nociceptors but retain mechanoreceptors
(Mishra et al., 2011). We first assessed cold sensitivity in naive
(uninjured) TrpV1CreDTAflox-stop mice and their wild-type litter-
mates in a dynamic thermal place cold aversion challenge.
While the littermate control mice rapidly manifested a prefer-
ence for moderate (11C–25C) rather than noxious cold
(4C–11C) temperatures, TrpV1CreDTAflox-stop mice displayed
no aversion to noxious cold. These data indicate that TrpV1
lineage nociceptors are essential for cold detection under
baseline conditions (Figure 5A).
Next, we determined the temporal development of tactile and
cold allodynia after SNI in the TrpV1 neuron ablated mice relative
to their littermate controls. TrpV1 DTA mice showed a total loss
of TrpV1 expression in the DRG (Figure S5A), indicating the effi-
ciency of the ablation. The tactile behavioral hypersensitivity was
fully apparent in these mice at 7 days post-SNI injury and
continued at similar levels until at least 21 days post-SNI
A
B C
Figure 5. Trpv1 Lineage Neuronal Deletion
Mice Develop Tactile, but Not Cold, Allody-
nia after SNI Injury
(A) When naive mice are given the choice
between two opposing temperatures, wild-type
control littermate (LM) mice move toward the
more ambient temperature, whereas Trpv1 DTA
mice do not. Each point on the graph measures
the amount of time spent on plate A in a 30-s
window (y axis) when the plate was set to the
temperature given on the lower x axis. The top x
axis gives the temperature of the alternate plate
for that time bin.
(B) TrpV1 lineage DTA mice and their LM control
counterparts develop tactile allodynia post-SNI.
Statistically significant differences between the
values from mice after SNI and their basal mea-
sures are shown (**p < 0.01). However, there was
no significant difference between the two curves
(two-way repeated-measures ANOVA).
(C) TrpV1 lineage DTA mice develop very
weak levels of cold allodynia relative to their LM
controls. Statistically significant differences be-
tween the values from mice after SNI and their
basal measures (**p < 0.01) and between wild-type
LM controls and TrpV1 DTAmice in cold sensitivity
(##p < 0.01) are shown (two-way repeated-mea-
sures ANOVA, Bonferroni post hoc test).
For (A), n = 9 (TrpV1-DTA), n = 10 (LM controls); for
(B) and (C), n = 8 (both groups). Error bars indicate
SEM. See also Figure S5.
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(Figure 5B). In contrast, TrpV1 DTA mice failed to develop cold
allodynia 7 or 14 days after nerve injury (Figure 5C). The lack of
normal cold- or injury-induced cold sensitivity in these animals
may reflect the absence of TrpM8 expression in the DRG relative
to wild-type controls (Figure S5B). At later time points (21 days),
injured TrpV1 DTAmice developed a slight level of cold allodynia
relative to naive TrpV1 DTAmice (Figure 5C). The mechanism for
this late and muted response is unclear, although it likely repre-
sents compensatory changes in gene expression/function in the
remaining (non TRPV1 lineage) intact sensory neurons that
enable them to develop sufficient cold thermoception to drive
the central circuits that produce cold allodynia. Some residual
TrpA1 (but not TrpM8) expression is present in the DRGs of
TrpV1 DTA mice (20% of wild-type levels) (Figure S5C), and
TrpA1 is implicated in neuropathic cold allodynia (del Camino
et al., 2010), suggesting this channel maybe the source of this
late-onset low-level activity. The early loss in cold allodynia in
TrpV1 DTA mice is consistent with the primarily neuronal gene
expression changes in the DRG that correlate with its onset.
Based on these findings, we conclude that an alteration in
TrpV1 lineage sensory neurons is required for early development
of this phenotype.
Peripheral Macrophages Are Crucial to the
Development of Tactile, but Not Cold, Allodynia
Genes whose expression pattern matched the time course of
tactile allodynia onset are primarily expressed in immune cells.
Specifically, they appear to be enriched in macrophages and
T cells (Figure 4G), two leukocyte populations present in DRGs
after nerve injury (Hu andMcLachlan, 2002; Moalem and Tracey,
2006) (see also Figures 7A and 7B). To assess whether circu-
lating macrophages have a role in mediating allodynia, we
transiently depleted them in C57BL/6 mice using liposomal
clodronate. Macrophages naturally phagocytose these lipo-
somes within the blood; this releases clodronate intracellularly
and results in their death. Following a single liposomal clodro-
nate dose, animals regenerate a full macrophage blood count
from bone marrow precursors over the next 2 weeks (Camilleri
et al., 1995). Animals administered with liposomal clodronate
1 day before nerve injury (SNI) developed minimal tactile allody-
nia at 7 and 10 days post-SNI relative to control mice treated with
empty liposomes (Figure 6A). However, clodronate-treated and
control animals developed cold allodynia to a similar extent
post-SNI (Figure 6B). By assaying the blood at 7 days post-
SNI, we found markedly reduced myeloid cells in clodronate-
treated mice relative to liposome controls (Figure 6C). These
changes also translated to the DRG tissue (Figures 6D and 6E),
which may explain the large differences in mechanical threshold
in the same mice (Figure 6F). We confirmed the decrease in
macrophages/monocytes by immunohistochemistry; liposome
control mice showed amarked IBA1 immunoreactivity in the ipsi-
lateral L3-5 DRGs 7 days post-SNI, and this was markedly
decreased in clodronate-treated mice (Figures 6G and 6H,
respectively). We further quantified the relative expression
within the injured DRG by qPCR of the macrophage/monocyte
markers CD68 and CD11b, which both showed significant
decreases relative to liposome control mice (Figures 6I and 6J,
respectively). In addition, we quantified the transcript of CD163
(a marker of tissue resident macrophages), which was strongly
decreased following clodronate treatment (Figure 6K).
Consequence of Absence of T and B Cells on Nerve-
Injury-Induced Tactile and Cold Hypersensitivity
To demonstrate whether in addition to macrophages, activated
T cells were also present in the ipsilateral DRG 7 days post-
SNI injury, we utilized a combination of a Lck-zsGreen mouse
line, which expresses the fluorescent marker zsGreen in acti-
vated T cells (Zhang et al., 2005), and immunostaining for
IBA1. In the uninjured Lck-zsGreen transgenic DRG, very few
labeled T cells were present and there was little IBA1 staining
(Figure 7A). In ipsilateral DRGs 7 days post-SNI, there were in
contrast many labeled T cells and a strong IBA1 signal (red, Fig-
ure 7B). To test whether the absence of T cells had any effect on
cold and tactile allodynia, we exploited Rag1/mice that lack T
and B cells (Figure 7C, left and middle). In agreement with our
previous observations (Costigan et al., 2009a), we found a
marked reduction in tactile hypersensitivity in Rag1/ animals
relative to their littermate controls (Figure 7D). We extended
this by showing that introducing CD4+/CD8+ T cells into Rag1/
mice (Figure 7C) could rescue the tactile allodynia phenotype for
at least 4 weeks post-SNI (Figure 7D). The full rescue of tactile
allodynia by T cells in reconstituted Rag1/ mice, which still
lack B cells, argues against a role for this latter immune cell
type in this phenotype (Figures 7C and 7D). In contrast, we wit-
nessed little difference in the extent of cold allodynia in Rag1/
animals (Figure 7E), suggesting that both T and B cells are
dispensable for that response.
Taken together, these data strongly support a role for of each
of these two leukocyte cell types (macrophages and T cells) in
the establishment of tactile allodynia after peripheral nerve dam-
age but demonstrate that they are dispensable for the develop-
ment of cold allodynia.
DISCUSSION
By assaying the development of two common clinical manifesta-
tions of stimulus-evoked neuropathic pain (cold and tactile allo-
dynia) (Jensen and Finnerup, 2014) at high temporal resolution,
we demonstrate that they develop over different time courses
in the first week post-surgery in the SNI model. This difference
led us to hypothesize that there may be mechanistic differences
underlying these two pain modalities and that these could
perhaps be revealed by correlating the changes in global tran-
script expression in the PNS in response to nerve injury with
the temporal evolution of the behavior. To investigate this, we
generated DRG expression array profiles beginning immediately
after the nerve injury and at a higher temporal definition than in
previous investigations (Costigan et al., 2010; Li et al., 2015).
To assay global transcript expression changes in the DRG
following SNI, we separated all of the potentially regulated genes
into co-regulated clusters using WGCNA, since groups of genes
with similar expression patterns across large datasets are often
functionally connected as part of the same tissue, cell type, or
biological pathway (Parikshak et al., 2015). There were relatively
few clustered groups of co-regulated transcripts in the injured
DRG over the 10 days following the injury (eight in total), with a
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temporal analysis suggesting an early pattern of neuronal gene
regulation followed later by regulation of immune transcripts.
Correlation of the distinct trajectories of cold and tactile hyper-
sensitivity onset respectively with gene expression further
suggested a link between the two. The patterns suggest pre-
dominant involvement of sensory neurons in the onset of cold
allodynia and a contribution of activated peripheral immune cells
in the generation of tactile allodynia. Next, we used a combina-
tion of genetically targeted and cell depletion protocols to test
these predictions.
TrpV1-mediated Cre expression in the embryo occurs in all
thermo-sensing progenitor neurons, which are consequently
deleted by DTA expression. This removes all TrpM8 expression
and, therefore, all normo-cold sensation in the adult mouse, as
shown here and in previous studies (McKemy, 2011; Mishra
et al., 2011). We demonstrate that ablating TrpV1 lineage noci-
ceptors results in a lack of cold allodynia after nerve injury,
consistent with this process occurring primarily through neuronal
mechanisms. In addition, recent independent data are entirely
consistent with cold allodynia occurring through neuronal
signaling pathways (Lippoldt et al., 2016).
Cold allodynia, like tactile allodynia following SNI, must be the
consequence of input to the CNS transmitted by uninjured sural
nerve axons. This raises the question of whether something
A B
C D E F
I J KG H
Figure 6. Mice Depleted of Peripheral Macrophages/Monocytes Using Clodronate Develop Delayed Tactile Allodynia but Normal
Neuropathic Cold Allodynia
(A) Clodronate-treated mice develop markedly less tactile allodynia post-peripheral nerve injury than empty-liposome-treated controls.
(B) Clodronate-treated mice develop significant levels of cold allodynia post-SNI. Statistically significant differences between the values frommice after SNI and
their basal measure (**p < 0.01) and between mice treated with clodronate or vehicle in tactile allodynia (##p < 0.01) are shown (two-way repeated-measures
ANOVA, Bonferroni post hoc test). Clodronate-treated C57BL/6mice develop significant levels of cold allodynia post-SNI (*p < 0.05, **p < 0.01), but there were no
significant differences in cold allodynia between clodronate- and vehicle-treated mice (p = 0.323; two-way repeated-measures ANOVA).
For (A) and (B), n = 10 clodronate, n = 13 vehicle.
(C–E) Levels of myelocytes (CD45+CD11b+CD11cSiglecFCD3) measured by FACS in blood (C) and DRG (D and E) 7 days after SNI in mice treated with
clodronate or vehicle.
(F) Mechanical threshold in these mice.
For (C)–(F), p values are given (unpaired Student’s t test).
(G and H) Iba1 immunoreactivity in the DRG from SNI mice treated with vehicle liposomes (G) or clodronate liposomes (H). Scale Bar: 100 mm.
(I–K) Real-time qPCR of the macrophage/monocyte markers CD68 (I), CD11b (J), and CD163 (K) in the DRG of SNI mice treated with liposomes or clodronate.
p values are given (n = 5 per group; unpaired Student’s t test).
Error bars indicate SEM.
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changes in these ‘‘uninjured’’ peripheral neurons due to the SNI
procedure, such that previously innocuous stimuli can now acti-
vate a set of nociceptors or if there is an abnormal reaction in the
CNS, such that the ‘normal input’ generated by innocuous tem-
peratures in spared fibers now elicits pain-like behavior? For the
former, one might speculate that injured sensory neurons may
produce paracrine signals in the DRG that somehow alter the
sensitivity of neighboring non-injured thermo-nociceptors to
cold. For the latter, as injured C-nociceptors become ectopically
active early following peripheral nerve injury (4–13 hr) (Kirillova
et al., 2011), this abnormal afferent drive could maintain central
sensitization altering the central processing of low-threshold
thermoceptor inputs in the dorsal horn, leading to them being
perceived as painful (Latremoliere and Woolf, 2009).
In spite of the marked reduction in cold allodynia seen in the
TrpV1DTA line, we found relatively normal levels of tactile allody-
nia in these mice, which rules out the specific need for this noci-
ceptor lineage in the production of this form of stimulus-evoked
pain hypersensitivity after nerve injury. These findings are in
agreement with previous reports showing that ablation of either
TrpV1 or Nav1.8 lineage nociceptor neurons does not alter
neuropathic tactile allodynia (Abrahamsen et al., 2008; Lager-
stro¨m et al., 2011; Mishra et al., 2011). Tactile allodynia must
require other sensory neurons for its manifestation, and indeed
many studies have indicated that it is carried by low-threshold
mechanoreceptors (Campbell and Meyer, 2006; Xu et al., 2015).
The correlation of immune related transcripts with the devel-
opment of tactile allodynia suggested that the immune system
may play a role in the development of this hypersensitivity, but
that these cells are largely dispensable for cold allodynia. To
test this prediction, we targeted two leukocyte populations,
macrophages/monocytes and T cells, as these cells represent
a large portion of the immune reaction within the DRG following
nerve injury (Hu and McLachlan, 2002; Moalem and Tracey,
Figure 7. T and B Cell-Deficient Rag1/ Mice Develop Normal
Neuropathic Cold Allodynia, but Not Complete Tactile Allodynia,
following SNI Injury
T cell reintroduction into Rag1/mice abolishes tactile sensitivity differences
present between Rag1/ mice and wild-type control littermates (LM) but
leaves cold allodynia unaltered.
(A and B) Immunohistochemistry for the monocyte/macrophage marker IBA1
(red) in noninjured (A) and 7-day SNI-injured DRG in Lck Cre-zsGreen mice,
which express labeled T cells (green) (B). Scale Bar: 50 mm.
(C) Representative FACS plots of CD4 versus CD8 cell counts from splenic
preparation showing cells positive for both markers in the wild-type and in
Rag1/ and Tmice, but notRag1/mice (top). Representative FACS plots of
CD4 versus B220 counts showing the presence of B cells in wild-type LMs, but
not Rag1/ or reconstituted Rag1/ mice.
(D)Rag1/mice develop less tactile allodynia post-SNI than their LM controls
(Rag versus WT, p = 0.003; Rag versus Rag and T, p = 0.002). Reconstituted
Rag1/ mice (Rag1/ and T) showed full levels of tactile sensitivity (WT
versus Rag and T, not significantly different). Significant differences between
the values after SNI and their basal measures are shown (**p < 0.01, Rag1/
mice versus WT littermates [blue #]; Rag1/ mice versus Rag and T [red #];
#p < 0.05, ##p < 0.01, two-way repeated-measures ANOVA, Bonferroni post
hoc test).
(E) Wild-type LMs, Rag1/, and T cell-reconstituted mice develop similar
neuropathic cold allodynia (no significant differences among the three curves).
For (D) and (E), error bars indicate SEM (wild-type LM, n = 15; Rag1/, n = 10;
Rag1/ and T, n = 15).
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2006), and found that both peripheral macrophages and T cells
contribute to the development of neuropathic tactile sensitivity
but minimally to cold allodynia.
T cells and macrophages play a major role in orchestrating the
actions of one another during the early and late phases of the im-
mune response (Biswas et al., 2012; Roberts et al., 2015). The
complex interplay between innate and adaptive components of
the immune system is a major component of the reaction of the
PNS to damage, with functional roles in clearance of debris and
promotion of regeneration (DeFrancesco-Lisowitz et al., 2015).
However, recruitment of these leukocytes following nerve injury
can lead to effects on sensory neurons that activate or sensitize
them, leading to neuropathic pain (Costigan et al., 2009b).
Following nerve injury, macrophage-derived signaling mole-
cules such as IL-1b, TNF-a, and CCL2 likely contribute to pain-
like hypersensitivity (Andrade et al., 2014; Schuh et al., 2014;
Zhu et al., 2014) as well as the initiation of axonal regrowth
(Dubovy´ et al., 2013). In turn, Th1 T cell-derived interferon-g
(IFN-g) can recruit macrophages to sites of inflammation and
cause pain (Liou et al., 2011), whereas type 2 inflammatory
cytokines, such as IL-4, IL-10, and TGF-b, can ameliorate neuro-
pathic pain-like behavior (Chen et al., 2015; Dengler et al., 2014;
Kiguchi et al., 2015). The balance between these pro- and anti-
inflammatory subsets in different experimental settings may
explain the differences seen between studies focused on the
role of T cells on neuropathic pain (Austin et al., 2012; Kiguchi
et al., 2015); some studies did not find any impact on the pain
phenotype of T cell actions (Sorge et al., 2015), whereas we
and several others have (Cao and DeLeo, 2008; Costigan
et al., 2009a; Kobayashi et al., 2015; Leger et al., 2011; Zhang
et al., 2014).
While the mechanisms by which macrophages and T cells
interact to co-produce a convergent set of changes in the DRG
that lead to tactile allodynia now need to be explored, our data
indicate that they must act on sensory fibers other than TrpV1
lineage nociceptors. Activated macrophages are seen preferen-
tially around injured large-diameter A-fiber sensory neuron cell
bodies in the DRG after sciatic nerve injury (Vega-Avelaira et al.,
2009), but the functional consequence of this on these sensory
neurons is still unknown. It is possible that activated immune cells
in the DRG may stimulate injured A-fibers into initiating ectopic
activity, which contributes to the maintenance of central sensiti-
zation in the dorsal horn, such that central pain neurons begin
to be activated by low-threshold mechanoreceptors. In the naive
state, only C-fibers can initiate central sensitization, but after
nerve injury, A-fibers develop this capacity by a phenotypic
switch (Decosterd et al., 2002), and this shift may be triggered
by immune cell activation in the DRG. Consistent with this,
ectopic firing of injured A-fiber neuronsmanifests later after nerve
injury than in C-fibers (ectopic A-fiber activity is seen at 4–7 days)
(Kirillova et al., 2011). Alternatively, spared high-threshold A-fiber
nociceptors may be sensitized by immune cell action following
peripheral nerve damage. Either of these mechanisms, or
possibly a combination of both,may lead tomechanical allodynia.
What we now show conclusively, however, is that themechanism
responsible is dependent on peripheral immune cells.
Distinct mechanistic etiologies for these two neuropathic
pain symptoms may in consequence require different treatment
strategies, if our findings translate to humans, one targeted at a
particular set of TRPV1 lineage nociceptors for patients whose
primary symptoms are cold allodynia and another for patients
with predominant tactile allodynia, which could incorporate
either targeting the actions of the immune component of nerve
injury (macrophages and/or T cells) or non-TRPV1-expressing
afferents (mechanoreceptors). Identifying the key elements of
immune-neural signaling that underlie the development of
allodynia after nerve damage using cell-specific profiling tech-
nologies will be important for developing targeted therapies for
peripheral neuropathic pain.
EXPERIMENTAL PROCEDURES
Experiments were performed in adult (9–10 weeks old) male C57BL/6J mice
(Jackson Laboratory [Jax], ME). Heterozygous TrpV1-Cre (strain 017769)
and heterozygous DTA stop animals (strain 010527) were bred together to
produce TrpV1 DTA animals. Rag1 null (strain 2216) mice were also used.
To reveal T cell infiltration in the injured DRG, we bred Lck-Cre (Jackson
Laboratory [Jax] 3802) mice with zsGreen reporter mice (Rosa-CAG-LSL-
ZsGreen1-WPRE) (Jax 7906). All studies performed in USA were reviewed
and approved by the IACUC at Boston Children’s Hospital under animal
protocols 15-04-2928R and 16-01-3080R. All experimental procedures per-
formed in Spain were conducted in strict accordance to European standards
(European Communities Council Directive 2010/63) and after approval of the
animal protocols by regional (Junta de Andalucı´a) and institutional (Research
Ethics Committee of the University of Granada, Spain) authorities.
Detailed description of the animal strains used and the experimental proced-
ures for surgeries (SNI), behavioral tests (von Frey test, acetone test and dy-
namic thermal place aversion test), immune cell depletion or reconstitution,
gene expression analysis by microarray, RNA-seq and real-time qPCR,
bioinformatics (weighted gene co-expression network analysis, correlation
between expression changes and the pain phenotype, functional enrichment
analysis, transcription-factor-binding site enrichment, and PPI network
analyses); fluorescence-activated cell sorting to determine myeloid cells
or T and B cells, and immunohistochemistry are described in Supplemental
Experimental Procedures.
Statistical Significance
Gene regulation in the expressionmicroarrays was determined by amoderated
F-statistics using Bioconductor packages. In the rest of the experiments,
multiple comparisons were analyzed using repeated-measures ANOVA
with Bonferroni post-test, and single comparisons were analyzed using an
unpaired Student’s t test. Statistical analyses were performed with SigmaPlot
12.0 software (Systat Software, CA), with significance defined as p < 0.05.
DATA AND SOFTWARE AVAILABILITY
The accession number for all microarray and RNA-seq datasets reported in
this paper is GEO: GSE102937.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and nine tables and can be found with this article online at
https://doi.org/10.1016/j.celrep.2018.01.006.
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